Related references
Note: Only part of the references are listed.Step-wise and punctuated genome evolution drive phenotype changes of tumor cells
Aleksei Stepanenko et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2015)
Ex Vivo Expanded Mesenchymal Stromal Cell Minimal Quality Requirements for Clinical Application
Maria Luisa Torre et al.
STEM CELLS AND DEVELOPMENT (2015)
Concise Review: Workshop Review: Understanding and Assessing the Risks of Stem Cell-Based Therapies
James A. Heslop et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Risk of tumorigenicity in mesenchymal stromal cell-based therapies-Bridging scientific observations and regulatory viewpoints
Lisbeth Barkholt et al.
CYTOTHERAPY (2013)
Culture expansion induces non-tumorigenic aneuploidy in adipose tissue-derived mesenchymal stromal cells
Marieke Roemeling-van Rhijn et al.
CYTOTHERAPY (2013)
Significant Acquisition of Chromosomal Aberrations in Human Adult Mesenchymal Stem Cells: Response to Sensebe et al.
Uri Ben-David et al.
CELL STEM CELL (2012)
Limited Acquisition of Chromosomal Aberrations in Human Adult Mesenchymal Stromal Cells
Luc Sensebe et al.
CELL STEM CELL (2012)
Optimisation of mesenchymal stromal cells karyotyping analysis: implications for clinical use
S. Muntion et al.
TRANSFUSION MEDICINE (2012)
Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue
C. K. Rebelatto et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Clarification of the nomenclature for MSC: The international society for cellular therapy position statement
EM Horwitz et al.
CYTOTHERAPY (2005)
Share Paper
